Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sanolla has developed the world’s first AI-ready infrasound stethoscope ("VoqX") that captures low-frequency body sounds not audible to humans. The device received FDA clearance and Israeli Health Ministry approval. Their proprietary AI algorithms enable advanced classification of cardiopulmonary diseases such as COPD, pneumonia, asthma, and cardiac conditions. The company also offers the PyXy home monitoring device for chronic disease management. Clinical results show promise for improved non-invasive diagnosis and early exacerbation detection; however, detailed published clinical trial data are not available yet.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sanolla.